abstract |
The invention relates to pharmaceutical preparations containing a special crystal modification of the 1,4-dihydro-2,6-dimethyl-4- (3-nitrophenyl) -3,5-pyridinedicarboxylic acid isopropyl (2-methoxyethyl) ester and a process for their manufacture. |